December 13, 2024 - 21:27

As Congress approaches a critical deadline, Senator Tammy Baldwin is focused on resolving pressing issues before the end of the current session. With only until December 20 to secure a funding agreement, the urgency has intensified. The potential for a government shutdown looms large if lawmakers fail to reach a consensus on budgetary matters.
Baldwin has emphasized the importance of bipartisan cooperation in tackling the challenges ahead. She is particularly concerned about the impacts of funding lapses on essential services and programs that millions of Americans rely on. The senator has been actively engaging with her colleagues to foster dialogue and find common ground on key appropriations.
As the clock ticks down, Baldwin remains hopeful that Congress can overcome partisan divides and finalize a deal that will ensure the government's continued operation. The coming weeks will be crucial in determining whether lawmakers can effectively address this "unfinished business" before the deadline arrives.
March 18, 2026 - 11:16
Five Key Takeaways from a Weekend Coding Class for Non-Technical MindsThe idea of building an app in a single weekend seemed like a distant fantasy, something reserved for seasoned developers. Yet, a recent weekend `vibe coding` class made that a tangible reality,...
March 17, 2026 - 21:39
Orange Bank & Trust Company Celebrates Women’s Leadership at Annual Bronx Women in Business EventOrange Bank & Trust Company recently hosted its second annual Bronx Women in Business event, a vibrant celebration of female entrepreneurship and leadership within the borough. The gathering...
March 17, 2026 - 04:07
Autonomous businesses – from Waymo to mattress stores – are on the riseThe familiar chime of a door opening to reveal an empty room is becoming an increasingly common retail experience. From driverless taxis to fully automated mattress showrooms, autonomous businesses...
March 16, 2026 - 18:22
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business HighlightsCue Biopharma has released its financial and operational results for the fourth quarter and full year ending 2025, detailing a period marked by strategic pipeline advancement and key corporate...